← back to search

Shu Liu

Guangdong Province Women and Children Hospital · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, MicroRNA in disease regulation, BRCA gene mutations in cancer, and Cancer Genomics and Diagnostics.
h-index
36
citations
4,062
works
253
NIH funding
primary concept
email

Recent publications

A novel radio-immunotherapy strategy: Gut microbiota metabolite combined with radioactive hydrogel for the treatment of low rectal cancer
Biomaterials 2025cited by 5position: middledoi
The DASH diet in diabetes related complications or comorbidities: an unexpected friend
Frontiers in Nutrition 2025cited by 1position: middledoi
Effect of miR-6767-5p on breast cancer cell phenotype and its regulatory mechanism.
2025cited by 1position: contributordoi
The impact and mechanisms of CRIP2 on the biological behavior of triple-negative breast cancer cells.
2025cited by 0position: contributordoi
The features of male breast cancer in China: A real-world study
The Breast 2024cited by 9position: middledoi
Global trends and forecasts of breast cancer incidence and deaths.
2023cited by 208position: contributordoi
Edible Insects: A New Sustainable Nutritional Resource Worth Promoting
Foods 2023cited by 86position: middledoi
FGFR families: biological functions and therapeutic interventions in tumors.
2023cited by 44position: contributordoi
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition
Nature Cancer 2022cited by 81position: middledoi
DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Genome Medicine 2022cited by 18position: middledoi
FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy
Acta Pharmaceutica Sinica B 2022cited by 9position: middledoi
Additional file 3 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Additional file 8 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Additional file 12 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Additional file 16 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Additional file 22 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Additional file 11 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Additional file 18 of DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data
Figshare 2022cited by 0position: middledoi
Serum-Derived Exosomal Proteins as Potential Candidate Biomarkers for Hepatocellular Carcinoma
ACS Omega 2021cited by 47position: middledoi
VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer.
2021cited by 23position: contributordoi
NAP1L1 Functions as a Tumor Promoter <i>via</i> Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
2021cited by 11position: contributordoi
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
2021cited by 8position: contributordoi
Identification and characterization of a novel circular bacteriocin, bacicyclicin XIN-1, from Bacillus sp. Xin1
Food Control 2020cited by 39position: middledoi
SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma.
2020cited by 24position: contributordoi
MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis.
2019cited by 38position: contributordoi
Identification of a highly specific <scp>DNA</scp> aptamer for <i>Vibrio vulnificus</i> using systematic evolution of ligands by exponential enrichment coupled with asymmetric <scp>PCR</scp>
Journal of Fish Diseases 2018cited by 29position: middledoi
Targeting YAP in malignant pleural mesothelioma
Journal of Cellular and Molecular Medicine 2017cited by 58position: middledoi
DPMIND: degradome-based plant miRNA–target interaction and network database
Bioinformatics 2017cited by 35position: middledoi
YAP promotes erlotinib resistance in human non-small cell lung cancer cells
Oncotarget 2016cited by 116position: middledoi
YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells
Oncotarget 2016cited by 54position: middledoi

Grants

Neuroprotective Engineering Based on Innate Responses to Stroke
NSF1403036$499,9222014–2020PIRePORTER
Engineering enhancement of endothelial cell retention on arterial substitutes
NSF0932131$299,5412009–2013PIRePORTER
Pattern Formation of Vascular Smooth Muscle Cells Subject to Mechanical Stretch
NSF0401781$308,8882004–2009PIRePORTER
Vascular Cell Death and Proliferation: Role of Mechanical Stretch
NSF9908591$294,9752000–2004PIRePORTER

Frequent collaborators

Liang You · Guizhou University4 papers (2013–2017)David M. Jablons · UCSF Helen Diller Family Comprehensive Cancer Center4 papers (2013–2017)Yi‐Lin Yang · Shandong University of Technology4 papers (2013–2017)Wenqian Zhang · Central South University3 papers (2016–2017)Zhidong Xu · University of California, San Francisco3 papers (2013–2016)Yuyuan Dai · Jinan University3 papers (2016–2017)Ping‐Chih Hsu · Memorial Hospital of South Bend3 papers (2016–2017)Yucheng Wang · Institute for Infocomm Research2 papers (2016–2017)Hui Wang · Chongqing Emergency Medical Center2 papers (2016–2017)Hui Li · Central South University2 papers (2016–2017)Li Cheng · Central South University2 papers (2016–2017)Bin Hu · Shanxi Medical University2 papers (2016–2017)Hualin Liu · Zhongshan Hospital1 papers (2020–2020)Ji Huang · South China Agricultural University1 papers (2017–2017)Feng Wei · Hebei Medical University1 papers (2022–2022)Bingyue Xin · Wenzhou Medical University1 papers (2020–2020)Huixue Liu · Nanjing Agricultural University1 papers (2023–2023)Tao Zuo · University of Alabama at Birmingham1 papers (2021–2021)Lin Hu · Wenzhou Medical University1 papers (2025–2025)Csaba J. Peto · University of California, San Francisco1 papers (2013–2013)